Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Yasuda

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Japanese Journal of Clinical Oncology|January 11, 2023
The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinomaToshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, et al.
Journal for Immunotherapy of Cancer|February 19, 2021
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumabShohei Fukuda, Kazutaka Saito, Yosuke Yasuda, et al.
BJU International|April 24, 2012
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatinKazutaka Saito, Shinji Urakami, Yoshinobu Komai, et al.
Anti-Cancer Drugs|August 3, 2020
Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary reportHiroshi Fukushima, Shohei Fukuda, Shingo Moriyama, et al.
The Journal of Biological Chemistry|August 31, 2007
Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2Naoko Kimura, Katsuyuki Ohmori, Keiko Miyazaki, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumabShumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, et al.
IJU Case Reports|March 4, 2025
A case of seminal vesicle metastasis from bilateral seminomaYusuke Aida, Yosuke Yasuda, Emiko Sugawara, et al.
Asian Spine Journal|July 9, 2026
Responsiveness and minimal clinically important difference of the Brief BESTest 12 months after surgery for lumbar spinal stenosis: a prospective cohort study in JapanTomoyoshi Sakaguchi, Masato Tanaka, Shinya Arataki, et al.
IJU Case Reports|July 3, 2025
An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch SyndromeYuki Shimozawa, Yosuke Yasuda, Emiko Sugawara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 10, 2020
Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless techniqueYosuke Yasuda, Kazutaka Saito, Hajime Tanaka, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Japanese Journal of Clinical Oncology|January 11, 2023
The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinomaToshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, et al.
Journal for Immunotherapy of Cancer|February 19, 2021
Impact of C-reactive protein flare-response on oncological outcomes in patients with metastatic renal cell carcinoma treated with nivolumabShohei Fukuda, Kazutaka Saito, Yosuke Yasuda, et al.
BJU International|April 24, 2012
Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatinKazutaka Saito, Shinji Urakami, Yoshinobu Komai, et al.
Anti-Cancer Drugs|August 3, 2020
Impact of sarcopenia on the efficacy of pembrolizumab in patients with advanced urothelial carcinoma: a preliminary reportHiroshi Fukushima, Shohei Fukuda, Shingo Moriyama, et al.
The Journal of Biological Chemistry|August 31, 2007
Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2Naoko Kimura, Katsuyuki Ohmori, Keiko Miyazaki, et al.
Asia-Pacific Journal of Clinical Oncology|November 23, 2021
Early cancer cachexia phenotype predicts survival of advanced urothelial cancer patients treated with pembrolizumabShumpei Yamamoto, Hiroshi Fukushima, Shohei Fukuda, et al.
IJU Case Reports|March 4, 2025
A case of seminal vesicle metastasis from bilateral seminomaYusuke Aida, Yosuke Yasuda, Emiko Sugawara, et al.
Asian Spine Journal|July 9, 2026
Responsiveness and minimal clinically important difference of the Brief BESTest 12 months after surgery for lumbar spinal stenosis: a prospective cohort study in JapanTomoyoshi Sakaguchi, Masato Tanaka, Shinya Arataki, et al.
IJU Case Reports|July 3, 2025
An Excellent Clinical and Radiological Response Pattern to Pembrolizumab in a Patient With Metastatic Adrenocortical Carcinoma and Lynch SyndromeYuki Shimozawa, Yosuke Yasuda, Emiko Sugawara, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|December 10, 2020
Outcomes of gasless laparoendoscopic single-port partial nephrectomy in 356 consecutive patients: Feasibility of a clampless and sutureless techniqueYosuke Yasuda, Kazutaka Saito, Hajime Tanaka, et al.
Pageof 11